Author

Wenliang Li

Observed name: W. Li

Institution: Shenzhen University

Observed institutions: Shenzhen University, Jilin University, Beaumont Health, Northwest Women's and Children's Hospital, First Hospital of Jilin University, Second Affiliated Hospital of Jilin University, State Key Laboratory of Advanced Electromagnetic Engineering and Technology, Huazhong University of Science and Technology

ORCID: 0009-0006-1206-103X

Observed ORCID: 0009-0006-1206-103X

OpenAlex ID: A5067659247

Comparison of disruption mitigation from shattered pellet injection with massive gas injection on J-TEXT

2021 · Y. Li, Z.Y. Chen, et al. · Nuclear Fusion · 34

Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy

2017 · W. Cui, X. Lu, et al. · Brazilian Journal of Medical and Biological Research · 17

144O Comparison of efficacy and safety of paclitaxel and capecitabine followed by capecitabine as maintenance therapy versus cisplatin and capecitabine therapy for advanced gastric cancer: a multicentre, randomised, active-controlled phase III study

2015 · X. Zhang, L. Shen, et al. · Annals of Oncology · 1

Correction: Synergistic crucible design and thermal-flow management for enhanced 4-inch AlN single crystal PVT growth: a combined numerical and experimental investigation

2025 · Wenliang Li, QianLing Liu, et al. · CrystEngComm

Thermal-Flow Field Coupling Simulation of AlN Single Crystals Grown by PVT Method

2025 · Jun Tan, Guangze He, et al. · Springer proceedings in physics

Comparison of the Safety of Prednisone Plus Dipyridamole Versus Prednisone Plus Valsartan in the Treatment of Children with Primary Nephrotic Syndrome.

2024 · Guoqiang Chen, Wenliang Li · Iranian Journal of Kidney Diseases

POS-168 Mosaic Pattern of Progenitor Cell Marker CD133 Expression to Identify Podocyte Proliferation Supports Collapsing Variant of Focal Segmental Glomerulosclerosis (FSGS)

2021 · A. Xiao, H. Kanaan, et al. · Kidney International Reports

446PD Second-line afatinib vs erlotinib for patients with squamous cell carcinoma of the lung in LUX-Lung 8: analysis of tumor and serum biomarkers

2016 · K.H. Lee, J.-C. Soria, et al. · Annals of Oncology

446PD Second-line afatinib vs erlotinib for patients with squamous cell carcinoma of the lung in LUX-Lung 8: analysis of tumor and serum biomarkers

2016 · K.H. Lee, J-C. Soria, et al. · Annals of Oncology

Works count: 9

Citation count: 52

H-index: 2

I10-index: 2